Epirubicin/paclitaxel/etoposide in extensive-stage small-cell lung cancer: a phase I-II study. [electronic resource]
Producer: 20060605Description: 1263-6 p. digitalISSN:- 0007-0920
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Carcinoma, Small Cell -- drug therapy
- Epirubicin -- administration & dosage
- Etoposide -- administration & dosage
- Female
- Humans
- Infusions, Intravenous
- Injections, Intravenous
- Lung Neoplasms -- drug therapy
- Male
- Maximum Tolerated Dose
- Middle Aged
- Paclitaxel -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.